Literature DB >> 16127762

Radiofrequency ablation for incidentally identified primary intrahepatic cholangiocarcinoma.

Witold Zgodzinski1, N-Joseph Espat.   

Abstract

Cholangiocarcinoma is the second most common primary hepato-biliary malignancy. The majority of patients with primary hepatic tumors are not suitable candidates for resection, due to advanced stage of the disease at presentation, anatomic limitations and medical co-morbidities. At present, radiofrequency ablation (RFA) may offer an alternative, feasible and safe therapy for selected patients with hepatic tumors, who are not otherwise candidates for hepatic resection. Herein, we present the case of successful RFA in a patient with a solitary, primary intrahepatic cholangiocarcinoma. The patient remained free of disease 24 mo after the procedure, and is still followed up. This is the first report of RFA application in the treatment of primary intrahepatic cholangiocarcinoma.

Entities:  

Mesh:

Year:  2005        PMID: 16127762      PMCID: PMC4320405          DOI: 10.3748/wjg.v11.i33.5239

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  4 in total

1.  Percutaneous radiofrequency interstitial thermal ablation of small hepatocellular carcinoma.

Authors:  H P Allgaier; P Deibert; I Zuber; M Olschewski; H E Blum
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

2.  Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis.

Authors:  S A Curley; F Izzo; L M Ellis; J Nicolas Vauthey; P Vallone
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

3.  Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients.

Authors:  S A Curley; F Izzo; P Delrio; L M Ellis; J Granchi; P Vallone; F Fiore; S Pignata; B Daniele; F Cremona
Journal:  Ann Surg       Date:  1999-07       Impact factor: 12.969

Review 4.  The epidemiology of cholangiocarcinoma.

Authors:  Yasser Shaib; Hashem B El-Serag
Journal:  Semin Liver Dis       Date:  2004-05       Impact factor: 6.115

  4 in total
  12 in total

Review 1.  Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer.

Authors:  J R A Skipworth; S W M Olde Damink; C Imber; J Bridgewater; S P Pereira; M Malagó
Journal:  Aliment Pharmacol Ther       Date:  2011-09-20       Impact factor: 8.171

Review 2.  Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009.

Authors:  Murad Aljiffry; Mark J Walsh; Michele Molinari
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

Review 3.  Management of unresectable intrahepatic cholangiocarcinoma: how do we decide among the various liver-directed treatments?

Authors:  Eugene J Koay; Bruno C Odisio; Milind Javle; Jean-Nicolas Vauthey; Christopher H Crane
Journal:  Hepatobiliary Surg Nutr       Date:  2017-04       Impact factor: 7.293

4.  Percutaneous ultrasound-guided thermal ablation for intrahepatic cholangiocarcinoma.

Authors:  H-X Xu; Y Wang; M-D Lu; L-N Liu
Journal:  Br J Radiol       Date:  2012-02-28       Impact factor: 3.039

Review 5.  Cholangiocarcinoma: modern advances in understanding a deadly old disease.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  J Hepatol       Date:  2006-09-25       Impact factor: 25.083

6.  [Is there a nonsurgical therapeutic approach to cholangiocellular carcinomas?].

Authors:  M Fuchs; W Schepp
Journal:  Chirurg       Date:  2006-04       Impact factor: 0.955

7.  Radiofrequency ablation for postoperative recurrences of intrahepatic cholangiocarcinoma.

Authors:  Ying Fu; Wei Yang; Wei Wu; Kun Yan; Bao-Cai Xing; Min-Hua Chen
Journal:  Chin J Cancer Res       Date:  2011-12       Impact factor: 5.087

Review 8.  Cholangiocarcinoma: a compact review of the literature.

Authors:  Yucel Ustundag; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

9.  Treatment of malignant liver tumors by radiofrequency ablation combined with low-frequency ultrasound radiation with microbubbles.

Authors:  Ai Junhua; Jin Yun; Wang Zhenzhou; Yang Ling; Luo Ding
Journal:  PLoS One       Date:  2013-01-10       Impact factor: 3.240

10.  Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.

Authors:  Chiyoko Makita; Tatsuya Nakamura; Akinori Takada; Kanako Takayama; Motohisa Suzuki; Yojiro Ishikawa; Yusuke Azami; Takahiro Kato; Iwao Tsukiyama; Yasuhiro Kikuchi; Masato Hareyama; Masao Murakami; Nobukazu Fuwa; Masaharu Hata; Tomio Inoue
Journal:  Radiat Oncol       Date:  2014-01-14       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.